Published in New England Journal of Medicine · View the paper (DOI)
In the multicenter clinical trial, TAVR showed superiority to open-heart surgery in low-risk patients with severe aortic stenosis. One-year mortality rates were significantly lower with TAVR, with 42 deaths vs 68 in the surgical group. The study also found shorter hospital stays and fewer strokes for TAVR patients.
Coverage from 2 institutions